Advancing Quality in Drug Products
The pharmaceutical industry is adopting digital tools, such as artificial intelligence and machine learning, to improve quality control and assurance. Regulators are increasingly expecting structured, machine-readable submissions, driving the need for strong data governance and harmonized processes.
The pharmaceutical industry is evolving with digital tools and sustainability practices. Quality control processes are being enhanced with AI and machine learning. AI is used for root-cause investigations, anomaly detection, and bioanalytical reliability. Regulators are adopting digital tools, such as the FDA's generative AI tool, Elsa. Digitalization is streamlining regulatory compliance and market access. The industry is moving towards certification by design, with real-time monitoring tools embedded in production.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.